050ab2b6862fffc232499d8cc462e0e3

3. CYTOKINE STORM ARRAY MARCA: RANDOX

BIOLORE LTDA·I·Colombia INVIMA·Expires February 22, 2034

Device classification

Risk class / Clase de Riesgo: I
Product type (Spanish): REACTIVOS IN VITRO
Product type (English): REACTIVOS IN VITRO

Registration information

Analysis ID: 050ab2b6862fffc232499d8cc462e0e3
Expire date: February 22, 2034

Authorized company / Fabricante

Name (Spanish): BIOLORE LTDA
Name (English): BIOLORE LTDA

Product use / Uso del Producto

Spanish

EL EVIDENCE MULTISTAT™ CYTOKINE STORM ARRAY ESTÁ DESARROLLADO PARA LA DETECCIÓN CUANTITATIVA SIMULTÁNEA DE IL-1BETA, IL-2, IL-6,IL-15, IFNGAMMA,_x000D_ TNFALPHA, MCP-1, FERRITINA Y DDIMER A PARTIR DE UNA ÚNICA MUESTRA DE PLASMA._x000D_

English

THE EVIDENCE MULTISTAT™ CYTOKINE STORM ARRAY IS DEVELOPED FOR THE SIMULTANEOUS QUANTITATIVE DETECTION OF IL-1BETA, IL-2, IL-6, IL-15, IFNGAMMA,_x000D_ TNFALPHA, MCP-1, FERRITIN, AND DDIMER FROM A SINGLE PLASMA._x000D_ SAMPLE

About this record

Access comprehensive regulatory information for 3. CYTOKINE STORM ARRAY MARCA: RANDOX (3. CYTOKINE STORM ARRAY MARCA: RANDOX) in the Colombia medical device market through Pure Global AI's free database. This I medical device is registered under INVIMA analysis ID 050ab2b6862fffc232499d8cc462e0e3 and manufactured by BIOLORE LTDA. The device was registered on February 22, 2034.

This page provides complete registration details including product type (REACTIVOS IN VITRO), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.